A Pseudo-humanized Mouse Model to Investigate Impact of the Oral Microbiota on Bronchopulmonary Dysplasia

Saturday, April 23, 2022

1:30 PM – 1:45 PM US MT

Location: Convention Center: Mile High Ballroom 4AB

CE: Enduring CME: 0.25

Publication Number: 1555.3

Mary Silverberg, University of Alabama at Birmingham, Birmingham, AL, United States; Ahmed Abdelgawad, University of Alabama School of Medicine, Birmingham, AL, United States; Amelia Freeman, University of Alabama at Birmingham, Birmingham, AL, United States; Luhua Qiao, UAB, Vestavia Hills, AL, United States; Namasivayam Ambalavanan, University of Alabama School of Medicine, Birmingham, AL, United States; Charitharth Vivek Lal, University of Alabama at Birmingham, AL, Birmingham, AL, United States; Samuel Gentle, UAB, Birmingham, AL, United States; Kent A. Willis, The University of Alabama at Birmingham, Birmingham, AL, United States

Presenting Author(s)

Mary Silverberg, MD
Fellow
University of Alabama at Birmingham
Birmingham, Alabama, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Mary Silverberg, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Ahmed Abdelgawad, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Amelia Freeman, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Luhua Qiao, Master: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Namasivayam Ambalavanan, MBBS MD: ● ProvePharm (Currently Ongoing) (Products/Services: Consultant).
● Radiometer (Currently Ongoing) (Products/Services: Consultant).
● ResBiotic (Currently Ongoing) (Products/Services: Advisory Committee).
● Shire (Currently Ongoing) (Products/Services: Consultant).

Charitharth Vivek Lal, MD: ● ResBiotic, Inc and Alveolud Bio, Inc. (Currently Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).

Samuel Gentle, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Kent A. Willis, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.